Clinical results of intensity-modulated radiotherapy for 250 patients with cervical and upper thoracic esophageal carcinoma

References

• Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.2010721296855
   PubMed Web of Science ®Google Scholar
• Lee DJ, Harris A, Gillette A, Munoz L, Kashima H. Carcinoma of the cervical esophagus: diagnosis, management, and results. South Med J. 1984;77(11):1365–1367. doi:10.1097/00007611-198411000-000046494955
   PubMed Web of Science ®Google Scholar
• Gong Y, Wang S, Zhou L, et al. Dosimetric comparison using different multileaf collimeters in intensity-modulated radiotherapy for upper thoracic esophageal cancer. Radiat Oncol. 2010;5:65. doi:10.1186/1748-717X-5-6520633283
   PubMed Web of Science ®Google Scholar
• Huang SH, Lockwood G, Brierley J, et al. Effect of concurrent high-dose cisplatin chemotherapy and conformal radiotherapy on cervical esophageal cancer survival. Int J Radiat Oncol Biol Phys. 2008;71(3):735–740. doi:10.1016/j.ijrobp.2007.10.02218164844
   PubMed Web of Science ®Google Scholar
• Uno T, Isobe K, Kawakami H, et al. Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus. Dis Esophagus. 2007;20(1):12–18. doi:10.1111/j.1442-2050.2007.00632.x17227304
   PubMed Web of Science ®Google Scholar
• Wang HW, Chu PY, Kuo KT, et al. A reappraisal of surgical management for squamous cell carcinoma in the pharyngoesophageal junction. J Surg Oncol. 2006;93(6):468–476. doi:10.1002/jso.2047216615159
   PubMed Web of Science ®Google Scholar
• Laterza E, Mosciaro O, Urso US, Inaspettato G, Cordiano C. Primary carcinoma of the hypopharynx and cervical esophagus: evolution of surgical therapy. Hepatogastroenterology. 1994;41(3):278–282.7959554
   PubMedGoogle Scholar
• Du XX, Yu R, Wang ZF, et al. Outcomes and prognostic factors for patients with cervical esophageal cancer undergoing definitive radiotherapy or chemoradiotherapy. Bosn J Basic Med Sci. 2019;19(2):186–194. doi:10.17305/bjbms.2019.387330877837
   PubMed Web of Science ®Google Scholar
• Li HX, Liu J, Cheng Y, Liu MN, Fang WT, Lv CX. Concurrent chemoradiotherapy for cervical esophageal squamous cell carcinoma: treatment results from a prospective observational study. Dis Esophagus. 2018;31:5. doi:10.1093/dote/dox144
   Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228–247. doi:10.1016/j.ejca.2008.10.02619097774
   PubMed Web of Science ®Google Scholar
• Bai W, Zhou Z, Zhen C, et al. Long-term efficacy of 159 cases of cervical and upper esophageal carcinoma treated with intensity-modulated radiotherapy. Chin J Radiol Med Prot. 2016;36(1):28–34. doi:10.3760/cma.j.issn.0254-5098.2016.01.005
   Google Scholar
• Kumabe A, Zenda S, Motegi A, et al. Long-term clinical results of concurrent chemoradiotherapy for patients with cervical esophageal squamous cell carcinoma. Anticancer Res. 2017;37(9):5039–5044. doi:10.21873/anticanres.1191928870931
   PubMed Web of Science ®Google Scholar
• Mendenhall WM, Sombeck MD, Parsons JT, et al. Management of cervical esophageal carcinoma. Semin Radiat Oncol. 1994;4(3):179–191. doi:10.1053/SRAO0040017910717106
   PubMedGoogle Scholar
• Grass GD, Cooper SL, Armeson K, Garrett-Mayer E, Sharma A. Cervical esophageal cancer: a population-based study. Head Neck. 2015;37(6):808–814. doi:10.1002/hed.2367824616217
   PubMed Web of Science ®Google Scholar
• Duan X, Zhao E, Cong T, Shen H, Xiao S, Qin Y. [Surgical management of cervical esophageal carcinoma in 16 cases]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2013;27(24):1347–1351.24669682
   PubMedGoogle Scholar
• Daiko H, Hayashi R, Saikawa M, et al. Surgical management of carcinoma of the cervical esophagus. J Surg Oncol. 2007;96(2):166–172. doi:10.1002/jso.2079517443746
   PubMed Web of Science ®Google Scholar
• Cao CN, Luo JW, Gao L, et al. Primary radiotherapy compared with primary surgery in cervical esophageal cancer. JAMA Otolaryngol Head Neck Surg. 2014;140(10):918–926. doi:10.1001/jamaoto.2014.201325233363
   PubMed Web of Science ®Google Scholar
• Wang HW, Kuo KT, Wu YC, et al. Surgical results of upper thoracic esophageal carcinoma. J Chin Med Assoc. 2004;67(9):447–457. doi:10.1111/j.1464-410X.2006.06272.x15617305
   PubMedGoogle Scholar
• Manshanden CG, Hulscher JBF, Hovius M, Fockens P, van Lanschot JJB, Obertop H. Limited resection for carcinoma of the upper thoracic oesophagus is not a realistic option. Eur J Surg Oncol (EJSO). 2000;26(6):561–566. doi:10.1053/ejso.2000.094711034806
   PubMedGoogle Scholar
• Zhu WG, Yu CH, Han JH, Li T, Zhou XL, Tao GZ. Feasibility and short-term efficacy of simplified intensity-modulated radiotherapy and concurrent chemotherapy for neck and upper thoracic esophageal carcinoma. Chin J Cancer. 2009;28(12):1265–1269. doi:10.5732/cjc.009.10215
   Google Scholar
• Esmati E, Maddah SA, Ghalehtaki R, et al. Outcomes of definitive chemoradiotherapy for cervical and upper thoracic esophageal cancers: a single-institution experience of a rare cancer. J Gastrointest Cancer. 2018. doi:10.1007/s12029-018-0081-8
   Web of Science ®Google Scholar
• Yu L, Wu JX, Gao YS, Li JY, Zhang YF, Ke J. Pros and cons of the gasless laparoscopic transhiatal esophagectomy for upper esophageal carcinoma. Surg Endosc. 2016;30(6):2382–2389. doi:10.1007/s00464-015-4488-z26416374
   PubMed Web of Science ®Google Scholar
• Lin SH, Wang L, Myles B, et al. Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys. 2012;84(5):1078–1085. doi:10.1016/j.ijrobp.2012.02.01522867894
   PubMed Web of Science ®Google Scholar
• Haefner MF, Lang K, Verma V, et al. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity. Radiat Oncol. 2017;12(1):131. doi:10.1186/s13014-017-0863-328810885
   PubMedGoogle Scholar
• McDowell LJ, Huang SH, Xu W, et al. Effect of intensity modulated radiation therapy with concurrent chemotherapy on survival for patients with cervical esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2017;98(1):186–195. doi:10.1016/j.ijrobp.2017.01.00328258892
   PubMed Web of Science ®Google Scholar
• Ma JB, Song YP, Yu JM, et al. Feasibility of involved-field conformal radiotherapy for cervical and upper-thoracic esophageal cancer. Oncol Res Treat. 2011;34(11):599–604. doi:10.1159/000334194
   Google Scholar
• Zhang WZ, Chen ZJ, Li DR, et al. [Dosimetric comparison between intensity-modulated radiotherapy and conformal radiotherapy for upper thoracic esophageal carcinoma]. Ai Zheng. 2009;28(11):1127–1131. doi:10.5732/cjc.008.1083919895730
   PubMedGoogle Scholar
• Zhu WG, Zhou K, Yu CH, et al. Efficacy analysis of simplified intensity-modulated radiotherapy with high or conventional dose and concurrent chemotherapy for patients with neck and upper thoracic esophageal carcinoma. Asian Pac J Cancer Prev. 2012;13(3):803–807. doi:10.7314/APJCP.2012.13.3.80322631652
   PubMedGoogle Scholar
• Zhao Q, Hu G, Xiao W, et al. Comparison of definitive chemoradiotherapy and radiotherapy alone in patients older than 75 years with locally advanced esophageal carcinoma: a retrospective cohort study. Medicine (Baltimore). 2017;96(35):e7920. doi:10.1097/MD.000000000000792028858114
   PubMed Web of Science ®Google Scholar
• Zhong H, Ma R, Gong L, et al. [Comparison of the prognostic value of the seventh and eighth edition of the AJCC esophageal cancer staging system for the patients with stage and esophageal squamous cell carcinoma]. Zhonghua Wai Ke Za Zhi. 2017;55(12):903–908. doi:10.3760/cma.j.issn.0529-5815.2017.12.00629224264
   PubMedGoogle Scholar